Global Phospholipids Market - 2024-2031

Global Phospholipids Market - 2024-2031

Global Phospholipids Market reached US$ 2.97 billion in 2023 and is expected to reach US$ 5.13 billion by 2031, growing with a CAGR of 7.03% during the forecast period 2024-2031.

Phospholipids are essential components with diverse applications due to their unique properties and functions. They can be sourced from soybeans, sunflowers, eggs and others and come in various types, including phosphatidylserine and phosphatidylcholine. Phospholipids are recognised for their various health-promoting properties, including cardiovascular health, cognitive function support and skin health improvement.

Phospholipids offer a range of functionalities, due to which they find applications in various industries including food and beverages, nutraceutical supplements, and pharmaceuticals with additional applications in other sectors. The growing consumer awareness is driving the adoption of phospholipids across multiple industries and contributing to market growth.

North America dominates the global market. The region struggles with a high prevalence of chronic diseases like heart disease and diabetes. According to the Centers for Disease Control and Prevention, 8.9% of US population was diagnosed with diabetes in 2021. Also, about 695,000 people in US died from heart disease in 2021. This necessitates effective treatments, and phospholipids play a crucial role in drug delivery and improving bioavailability, driving its demand in the regional market.

Dynamics

Growing Demand for Phospholipids in Pharmaceutical and Nutraceutical Industries

As chronic diseases like heart disease and diabetes become more prevalent, the demand for effective treatments increases. People are more interested in maintaining good health and creating a market for nutraceutical and pharmaceutical products. The growing focus on preventive healthcare fuels the demand for pharmaceutical and nutraceutical products containing phospholipids which are seen as beneficial for overall health.

Phospholipids help drugs get absorbed better by the body, making them more effective. Many drugs are poorly soluble in water. Phospholipids fix poorly the solubility of certain drugs allowing for better delivery. As the pharmaceutical and nutraceutical sectors continue to expand globally, the demand for phospholipids is expected to rise significantly.

New and Innovative Launches

The new products and technologies introduced into the market increase the exploration and utilisation of phospholipids in various end-use applications with new and accessible utility options, expanding the market growth. For instance, in May 2024, Vitafoods Europe launched MPL+, a marine phospholipid cellular nutrition and innovative product. MPL+ technology platform utilises the potential of phospholipids as a unique delivery platform to bring innovations to the nutraceuticals industry.

Similarly, in November 2022, Aker BioMarine launched a new PL+ technology platform that uses phospholipids from krill to improve the solubility and emulsification of ingredients with poor bioavailability or absorption rates. The PL+ technology comes encapsulated in soft gels with challenging ingredients, such as cannabidiol, curcumin and others. According to Aker BioMarine, PL+ can boost absorption by up to 25 times.

High Costs Associated with Phospholipids

One major hindering factor for the global phospholipids market is the high cost associated with production and extraction processes. Phospholipids aren't easy to get from their natural sources like soybeans or eggs. These complex extraction techniques require expensive equipment, advanced technology and a skilled workforce. Efficient extraction relies on sophisticated technology, adding to the overall cost.

In addition, raw material fluctuations can also add fuel to the higher prices. The cost of soybeans, eggs, or sunflower seeds, the main sources of phospholipids, can change significantly. This instability makes it difficult for producers to predict and manage their overall pricing. This can discourage companies from entering the market and limit the affordability of phospholipid products for consumers.

Segment Analysis

The global phospholipids market is segmented based on type, source, functionality, application and region.

Rising Need for Functional Food and Beverage Products

The global phospholipids market is segmented based on application into food & beverage, nutraceutical supplements, pharmaceuticals and others. The food & beverage segment accounts for the largest share of the global market. The multifunctional properties of phospholipids, coupled with consumer demand for healthier, clean-label food and beverage products, contribute to the dominance of the food and beverage application segment in the global phospholipids market.

People are increasingly prioritizing healthy eating and functional foods that offer additional health benefits. With a growing emphasis on health and wellness, consumers are increasingly seeking out food and beverage products that offer functional benefits. Phospholipids play a crucial role in improving the texture and mouthfeel of food and beverage products.

In the food and beverage industry, phospholipids are widely used emulsifiers in products such as margarine, chocolate, dressings, and beverages to create stable emulsions, improve texture, and enhance mouthfeel. Phospholipids can be added to functional beverages to enhance nutrient delivery, improve stability, and impart health benefits, aligning with consumer preferences for functional and convenient beverage options.

Geographical Penetration

Greater Presence of Phospholipids Utilising Industries in North America

North America dominates the global market with the presence of various leading pharmaceutical and nutraceutical companies that heavily rely on phospholipids for various applications. These industries are at the forefront of research and development, driving demand for innovative phospholipid products. The region's well-established pharmaceutical industry utilizes phospholipids in drug delivery systems and formulations.

Additionally, the region has a robust food and beverage industry, where phospholipids are used as emulsifiers and functional ingredients in a wide range of products. The presence of key market players and research institutions focused on lipid science also contributes to the region's dominance. The region is benefited from the presence of advanced technology and skilled labor, which leads to efficient extraction and processing methods.

Competitive Landscape

The major global players in the market include Cargill, Inc., Archer Daniels Midland Company, Bunge Ltd, Lipoid GmbH, VAV Life Sciences, American Lecithin Company, Kewpie Corporation, Lecico GmbH, Nabros Pharma Pvt. Ltd., and Croda International Plc.

COVID-19 Impact Analysis

The COVID-19 pandemic had both positive and negative impact on the global phospholipids market. During the initial phases of the pandemic, lockdowns, travel restrictions and disruptions in transportation networks led to challenges in the supply chain for raw materials and finished phospholipid products. This resulted in delays in production, procurement difficulties and increased logistics costs for manufacturers and suppliers.

The pandemic altered consumer behaviours and preferences, leading to changes in demand for phospholipid-containing products, due to an increased focus on health and wellness. There was increased demand for certain pharmaceutical formulations and functional foods with immune-boosting ingredients. The pharmaceutical and nutraceutical industries, which are significant consumers of phospholipids, experienced varying impacts, positively impacting the market growth.

By Type
• Phosphotidylserine
• Phosphotidylcholine
• Others

By Source
• Soy
• Sunflower
• Egg
• Others

By Functionality
• Emulsifying
• Wetting & Dispersion
• Thickening & Gelling
• Nutrient Delivery

By Application
• Food & beverage
• Nutraceutical Supplements
• Pharmaceuticals
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Russia
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Key Developments
• In May 2024, Vitafoods Europe launched MPL+, a marine phospholipid cellular nutrition and innovative product. MPL+ technology platform utilises the potential of phospholipids as a unique delivery platform to bring innovations to the nutraceuticals industry.
• In November 2022, Aker BioMarine launched a new PL+ technology platform that uses phospholipids from krill to improve the solubility and emulsification of ingredients with poor bioavailability or absorption rates.
• In January 2021, NZMP, a dairy ingredient-solutions brand by global dairy mainstay Fonterra, launched milk phospholipids. Naturally present in milk, these complex lipids are clinically proven to help manage the effects of stress, to allow consumers to stay focused and positive under stress.

Why Purchase the Report?
• To visualize the global phospholipids market segmentation based on type, source, functionality, application and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of phospholipids market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global phospholipids market report would provide approximately 70 tables, 64 figures and 243 pages.

Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies